ArticleFrontiers in oncology2026

Case Report: Niraparib-abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases.

Ismaela Anna Vascotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.